Answers are grounded in this paper and cite their sources.
Evaluates extraction efficiency in bio-based long-chain dicarboxylic acid production, indicating key factors for process design.
Efficient recovery of long-chain dicarboxylic acids (LCDAs) from aqueous fermentation broths is a key challenge for the industrial development of bio-based LCDA production. This study evaluates liquid–liquid extraction (LLE) as a downstream recovery strategy, comparing physical extraction (PE) and reactive extraction (RE) for DCA 12, DCA 16, and DCA 18. The novelty of this work lies in demonstrating that LCDA extraction is governed by mechanisms fundamentally different from those of short- and medium-chain dicarboxylic acids. Whereas shorter chain dicarboxylic acids are mainly controlled by dissociation degree, LCDA recovery is strongly influenced by carbon-chain apolarity, low aqueous solubility, and compound losses through agglomeration, precipitation, and/or micellization. PEs enabled the selective recovery of the more hydrophobic DCA 16 and DCA 18 over DCA 12, confirming the dominant role of chain length in LCDA separation. In contrast, RE with Aliquat®336 maximized total LCDA recovery, achieving extraction efficiencies above 85%, but with reduced selectivity. Validation in autoclaved fermentation broth from UCO feedstock confirmed the potential of Aliquat®336 in octanol for high LCDA recovery, while revealing lower extraction efficiencies than in model mixtures due to broth matrix complexity. Overall, this study establishes LLE as a promising platform for LCDA recovery and highlights that future downstream process design must balance total recovery, chain-length selectivity, and broth-specific matrix effects.
No takes yet. Share an insight, caveat, or question.
Mondal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: